DB Realtime Indikationen: Dax: 9411,50 Gestiegen 0.89% | Tecdax: 1158,25 Gestiegen 0.17% | DJ-: 16250 Gestiegen 0.47% | Nasdaq100: 3537,25 Gestiegen 1.11% | Gold: 1202,90 Gestiegen 1.19%
Datum/Zeit Mitteilung Quelle
Aktuell keine Ad-Hoc Mitteilungen zugeordnet.
Datum/Zeit Nachricht Quelle
Aktuell keine Unternehmensmeldungen zugeordnet.
Datum/Zeit Nachricht Quelle
18.Nov / 10:59 DGAP-DD: Allianz Se english Globenewswire Globenewswire
Datum/Zeit Nachricht Quelle
Aktuell keine Chartanalysen zugeordnet.
Hier wurde das Unternehmen ALLIANZ SE erwähnt:
Datum/Zeit Nachricht Quelle
17.Dec / 16:53 2020 Foresight Report: Reinsurance Hubs prnewswire.com  PR-Newswire
15.Nov / 23:25 JPMorgan Chase agrees to pay $4.5 billion on mortgage security claims reuters.com  Reuters
04.Nov / 20:44 Pimco Total Return loses title as world's largest mutual fund reuters.com  Reuters
02.Nov / 13:51 Pimco wagt neues Aktien-Abenteuer cash.ch  CASH.ch
Zuletzt besuchte Unternehmensseiten Relevante Firmen zur ALLIANZ SE Aktie
Seite
Unternehmen
Commerzbank   
Allianz Se   
Deutsche Postbank   

ALLIANZ SE Aktie

DJ DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution DJ DGAP-PVR: STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution STRATEC Biomedical AG 16.12.2013 15:40 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. =-------------------------------------------------------------------------- Allianz SE, Munich, Germany, notified us on December 12, 2013 pursuant to section 21 (1) of the German Securities Trading Act (WpHG) as follows: 'We hereby give notice pursuant to section 21 (1) of the German Securities Trading Act (WpHG) that our voting rights in STRATEC Biomedical AG, Gewerbestr. 37, 75217 Birkenfeld, Germany, exceeded the threshold of 5% on December 10, 2013 and amounted to 5.11% of all voting rights in the company, corresponding to 601,001 of the total 11,770,245 voting rights. These voting rights are attributed to us pursuant to section 22 (1) sentence 1 number 1 of the German Securities Trading Act (WpHG) and pursuant to section 22 (1) sentence 1 number 6 in conjunction with sentence 2 of the German Securities Trading Act (WpHG). The 600,000 voting rights attributable to us pursuant to section 22 (1) sentence 1 number 1 of the German Securities Trading Act (WpHG) are held via the following subsidiaries controlled by us whose share of voting rights in STRATEC Biomedical AG amounted in each case to 3% or more: Allianz Europe B.V., Allianz Holding France SAS, Allianz France S.A. and Allianz I.A.R.D. S.A. These 600,000 voting rights were also attributable to us pursuant to section 22 (1) sentence 1 number 6 in conjunction with sentence 2 of the German Securities Trading A... Weiter


Wie bewerten Sie diese Seite? (1 = sehr gut, 6 = schlecht) 1 2 3 4 5 6